<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322097</url>
  </required_header>
  <id_info>
    <org_study_id>833511</org_study_id>
    <nct_id>NCT04322097</nct_id>
  </id_info>
  <brief_title>Mechanisms of Upper Airway Obstruction</brief_title>
  <official_title>Characterizing Mechanisms of Upper Airway Obstruction During Drug-Induced Sleep Endoscopy (DISE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to examine underlying mechanisms of action of lingual muscles&#xD;
      in the maintenance of airway patency during sleep. The investigators' major hypothesis is&#xD;
      that specific tongue muscles are responsible for relieving upper airway obstruction during&#xD;
      sleep.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea (OSA) is characterized by recurrent upper airway obstruction due to&#xD;
      inadequate muscle tone during sleep leading to nocturnal hypercapnia, repeated oxyhemoglobin&#xD;
      desaturations and arousals. Continuous positive airway pressure (CPAP) is the therapeutic&#xD;
      mainstay for OSA, but adherence remains poor. The loss of motor input to the tongue during&#xD;
      sleep has been implicated as a cause for upper airway collapse. Activation of tongue muscles&#xD;
      with implanted hypoglossal nerve stimulators is an effective therapy for some OSA patients.&#xD;
      Nevertheless, approximately 1/3 of OSA patients did not respond to hypoglossal nerve&#xD;
      stimulation despite rigorous selection criteria, leaving large segments of CPAP intolerant&#xD;
      patients at risk for OSA-related morbidity. Thus, there is a critical knowledge gap in the&#xD;
      role of lingual muscle activity in the maintenance of airway patency.&#xD;
&#xD;
      The current study is designed to examine underlying mechanisms of action of lingual muscles&#xD;
      in the maintenance of airway patency during sleep. The investigators' major hypothesis is&#xD;
      that specific tongue muscles are responsible for relieving upper airway obstruction during&#xD;
      sleep. To address this hypothesis, the investigators will (1) selectively stimulate specific&#xD;
      lingual muscle groups (viz., protrudors and retractors) and measure effects on airway patency&#xD;
      during Drug Induced Sleep Endoscopy (DISE). The investigators will also (2) correlate&#xD;
      responses in patency to alterations in tongue morphology (as assessed with ultrasound&#xD;
      imaging). A final goal is to (3) examine the impact of anatomic factors (e.g., the size of&#xD;
      the maxillo-mandibular enclosure) on airway responses to stimulation.&#xD;
&#xD;
      Objectives (all primary and secondary objectives)&#xD;
&#xD;
        1. To assess effects of stimulating specific lingual muscles on upper airway patency during&#xD;
           DISE and on tongue morphology.&#xD;
&#xD;
           The investigators hypothesize that stimulation will lead to improvements in upper airway&#xD;
           patency during DISE when tongue protrudors are stimulated, and that concomitant&#xD;
           stimulation of retractors will augment this response.&#xD;
&#xD;
        2. To correlate improvements in upper airway patency during sleep with stimulation to&#xD;
           alterations in tongue shape and position when stimulating during DISE.&#xD;
&#xD;
           The investigators hypothesize that the restoration of airway patency during sleep will&#xD;
           be associated with anterior tongue movement and preservation of tongue shape when&#xD;
           stimulated during DISE.&#xD;
&#xD;
        3. To assess whether craniofacial morphology predicts improvements in pharyngeal patency&#xD;
           during DISE with stimulation.&#xD;
&#xD;
      The investigators hypothesize that maxillo-mandibular restriction will be associated with&#xD;
      diminished responses in airway patency to stimulation during DISE.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2020</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper airway critical pressure (Pcrit)</measure>
    <time_frame>Within 3 months of enrollment</time_frame>
    <description>Measurement of airway collapsibility (cmH2O)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharyngeal compliance</measure>
    <time_frame>Within 3 months of enrollment</time_frame>
    <description>area/pressure in cm2 per cmH2O</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amax</measure>
    <time_frame>Within 3 months of enrollment</time_frame>
    <description>Measurement of maximal pharyngeal cross-sectional area (in cm-squared)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Segmental Airway Resistances</measure>
    <time_frame>Within 3 months of enrollment</time_frame>
    <description>Measurement of pharyngeal resistances upstream and downstream to site of collapse (cmH2O/l/s)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>DISE patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>DISE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lingual Muscle Stimulation</intervention_name>
    <description>Tongue protrudor and retractor muscles will be stimulated separately and in combination</description>
    <arm_group_label>DISE patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Mandibular advancement</intervention_name>
    <description>Outcome variables will be assess with and without mandibular advancement</description>
    <arm_group_label>DISE patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Postural maneuvers</intervention_name>
    <description>Outcome variables will be measured with and without postural maneuvers</description>
    <arm_group_label>DISE patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (≥ 22yrs)&#xD;
&#xD;
          -  Moderate to severe obstructive sleep apnea (AHI ≥ 20)&#xD;
&#xD;
          -  No underlying cardiac disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant cardiac disease, unstable or recent cardiac events&#xD;
&#xD;
          -  Active pulmonary, liver, or renal disease&#xD;
&#xD;
          -  Uncontrolled hypertension (BP&gt;160/100)&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
&#xD;
          -  Major psychiatric disease&#xD;
&#xD;
          -  Lifestyle considerations by the use of excessive alcohol, tobacco, or drugs and&#xD;
             involvement in shift work occupations that preclude study in the laboratory&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Anticoagulation therapy (e.g. Coumadin, Dabigatran)&#xD;
&#xD;
          -  MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raj C Dedhia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Everett Seay</last_name>
    <phone>2156158777</phone>
    <email>everett.seay@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj Dedhia, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Raj Dedhia, MD</investigator_full_name>
    <investigator_title>Associate Professor, Director, Division of Sleep Surgery</investigator_title>
  </responsible_party>
  <keyword>upper airway</keyword>
  <keyword>pharynx</keyword>
  <keyword>collapsibility</keyword>
  <keyword>compliance</keyword>
  <keyword>drug-induced sleep endoscopy</keyword>
  <keyword>hypoglossal stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 11, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT04322097/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

